Quality Assurance
Quality Assurance
DATED
1.0 APPROVAL:
1.1 Pre-Approval: The approval of this protocol will be joint responsibility of the following function area:
1.2 Post-Approval: The approval of this protocol will be joint responsibility of the following function area:
1.3 Final-Approval: The final approval of this protocol will be joint responsibility of following function
area:
2.0 Principal : The purpose of self inspection is to evaluate the section of the manufacturing facility
compliance with GMP in all aspects of production and quality control The self inspection program is
designed to detect any shortcoming in the implementation of GMP. The audit team will be responsible
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 3 of 35
to evaluate the implementation of GMP objectively. The head of the department will be responsible for
implementation of the corrective action.
The person of the self-inspection team should be familiar with GMP and related to the respective field
3.1 Is a complete index and a complete set of applicable SOPs available in the
department ?
_____________________________________________________________
______________________________________________________________
_________________________________________________________
_________________________________________________________
_________________________________________________________
_________________________________________________________
4. Personnel
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 6 of 35
____________________________________________________________
_____________________________________________________________
* GMPs
* SOPs
* GLPs
____________________________________________________________
_____________________________________________________________
4.3 Question several employees about the operations they are performing. Are they
knowledgeable about their job functions ?
____________________________________________________________
_____________________________________________________________
4.4 Have the employees undergone training according to the relevant SOP ?
______________________________________________________________
_____________________________________________________________
4.5 Are all employees attired according to the appropriate germinating SOP ?
______________________________________________________________
_____________________________________________________________
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 7 of 35
4.6 Are detailed , written job descriptions available for all employees ?
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
____________________________________________________________
____________________________________________________________
5.2 Is there a comprehensive checklist for batch record review prior to release ?
____________________________________________________________
____________________________________________________________
5.3 Is there a tracking procedure in place to ensure that a batch record with a
deviation report attached to it cannot be released prior to the completion of any
required investigation ?
____________________________________________________________
____________________________________________________________
____________________________________________________________
6. Deviation Reports
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 9 of 35
6.1 Select three manufacturing deviation report (MDRs) prepared within the last
six months.
__________________________________________________________
__________________________________________________________
6.1.2 Does the relevant SOP require a written investigation and follow-up on
implementation of recommendations ?
__________________________________________________________
__________________________________________________________
6.1.3 Are the MDRs filled out in accordance with the SOP ?
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
6.1.5 Have recommendations been made to prevent the deviation from recurring ?
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
6.2 Examine the daily deviation reports from the three months preceding the audit.
Is there follow-up to prevent recurrence .
_________________________________________________________
__________________________________________________________
6.2.1 Select three reports at random. Are they filled out in accordance
with the relevant SOP ?
_________________________________________________________
__________________________________________________________
6.3 Review the monthly summaries of all deviations( not product specific) for the
six months preceding the audit. Are there deviations that recur more than once ?
_________________________________________________________
__________________________________________________________
7.1 Are all changes that may impact product quality authorized by Quality
Assurance prior to implementation ?
_________________________________________________________
__________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
7.2.2 Were any required tests performed and the results evaluated prior to closing
the forms ?
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
8.1 Examine three product annual reviews completed at least three months prior to
the audit.
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
8.1.4 Is there a record of examination of reserve samples for the products reviewed?
Were the samples found to be satisfactory ?
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
9. Self-Inspection
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 13 of 35
9.1 Is there an SOP that requires that self-inspection be performed in all Deptt ?
___________________________________________________________
__________________________________________________________
___________________________________________________________
__________________________________________________________
___________________________________________________________
__________________________________________________________
9.4 Are written reports available for all inspections performed during the past year ?
___________________________________________________________
__________________________________________________________
___________________________________________________________
__________________________________________________________
10. Complaints
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 14 of 35
__________________________________________________________
____________________________________________________________
____________________________________________________________
___________________________________________________________
___________________________________________________________
10.2.3 Could any of the above complaints affect other batches of the product and,
if so , has an investigation been initiated and appropriate action taken ?
___________________________________________________________
___________________________________________________________
10.3 Examine the list of complaints for the year preceding the audit. Are there
products that have several complaints and , if so, has appropriate corrective
action been implemented ?
___________________________________________________________
___________________________________________________________
____________________________________________________________
____________________________________________________________
___________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
11.2.3 Is there written evidence that the destruction order has been carried out ?
___________________________________________________________
__________________________________________________________
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 16 of 35
_________________________________________________________
_________________________________________________________
12.2 Examine the list of special releases for the current year Select three batches.
1.
2.
3.
____________________________________________________________
____________________________________________________________
12.2.3 Are there any products that have more than one special release , if so, is the
first batch referred to in the decision to release the later batch ?
____________________________________________________________
____________________________________________________________
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 17 of 35
13.1 Examine the list of rejected batches for the current year.
Select three batches.
1.
2.
3.
_________________________________________________________
________________________________________________________
_____________________________________________________________
_____________________________________________________________
13.1.4 Are there any products that have more than one rejected batch and ,
if so , has corrective action been recommended and implemented ?
___________________________________________________________
___________________________________________________________
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 18 of 35
14.1 Is there a written procedure for holding , testing and reprocessing returned
drug products ?
____________________________________________________________
____________________________________________________________
14.2 Examine the list of returned goods for the current year.
Select three batches.
14.2.1 Is there a record for each batch , including the following details ?
* Name of Customer
* Name and strength of the product
* Batch number
* Reason for return
* Quantity returned
* Date of disposition
* Ultimate disposition
____________________________________________________________
____________________________________________________________
1. _______________________________________________________
2. ______________________________________________________
3. ______________________________________________________
1. _______________________________________________________
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 19 of 35
2. ______________________________________________________
3. ______________________________________________________
_______________________________________________________
______________________________________________________
14.2.5 Could the reason for any of the returns implicate other batches of the
product and , if so , has an investigation been initiated and appropriate
action taken ?
_______________________________________________________
______________________________________________________
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 20 of 35
15. Recalls
__________________________________________________________
_________________________________________________________
15.2 Have there been any recalls during the current year ?
15..2.1 Specify :
__________________________________________________________
_____________________________________________________
______________________________________________________
________________________________________________________
15.2.4 Could the reason for the recall implicate other batches of the product
and , if so , has an investigation been initiated and appropriate action
taken ?
___________________________________________________________
____________________________________________________________
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 21 of 35
16. Facilities
__________________________________________________________
16.2 Is the laboratory neat and orderly with sufficient space for equipment and
operations ?
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 22 of 35
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
17.1.4 Is there documented evidence that the person who performs the
preventive maintenance is qualified to do so ?
__________________________________________________________
__________________________________________________________
17.2 Select three major instruments used in the laboratory.
1. ________________________ ID No. _________________
2. ________________________ ID No. _________________
3. _______________________ ID No. _________________
_________________________________________________
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 23 of 35
_________________________________________________
_________________________________________________
_________________________________________________
_________________________________________________
_________________________________________________
_________________________________________________
_________________________________________________
_________________________________________________
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 24 of 35
18.1 Is a specific person responsible for the receipt of samples for testing ?
__________________________________________________________
__________________________________________________________
18.2 Is there a written SOP describing sample receipt and recording (logging in) ?
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
18.5 What happens to samples after testing and reporting are completed ?
__________________________________________________________
__________________________________________________________
18.6 Is there a time limit on how long a sample may remain in the laboratory
prior to testing ?
__________________________________________________________
__________________________________________________________
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 25 of 35
19.1 Are there approved test procedures available for all tests performed in the
laboratory ?
___________________________________________________________
___________________________________________________________
19.2 Is there a written procedure for ensuring that all pharmacopoeia procedures
are updated when a supplemental monograph is issued ?
___________________________________________________________
___________________________________________________________
19.3 Examine the work currently being performed on one of the HPLCs.
Product Name : ______________________________________________
Batch No. ____________________________________________________
17.3.1 Is the test procedure at hand ?
___________________________________________________________
___________________________________________________________
19.3.2 Is it up-to-date ?
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
19.3.4 Has the test method been validated for precision and reliability ?
___________________________________________________________
___________________________________________________________
________________________________________________________
________________________________________________________
19.3.6 Has the analyst recorded all the relevant details of the product being
tested , including the attachment of printouts or records of weighings?
________________________________________________________
________________________________________________________
________________________________________________________
________________________________________________________
19.3.8 Is there a reference to the test method used in the analyst's notebook?
________________________________________________________
________________________________________________________
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 27 of 35
______________________________________________________________
_______________________________________________________________
________________________________________________________
________________________________________________________
20.1.5 Is there a record of the instrument used for testing together with any
raw data ?
________________________________________________________
________________________________________________________
______________________________________________________
________________________________________________________
20.1.7 Are all charts, graphs and printouts labelled with the
* Product name and batch number ?
* Date of the test ?
______________________________________________________
________________________________________________________
20.1.8 How are raw data transferred from notebook to the final report ?
______________________________________________________
________________________________________________________
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 28 of 35
__________________________________________________________
_________________________________________________________
__________________________________________________________
_________________________________________________________
__________________________________________________________
_________________________________________________________
__________________________________________________________
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 29 of 35
21.Standard Solutions
_________________________________________________________
_________________________________________________________
_________________________________________________________
_________________________________________________________
_________________________________________________________
_________________________________________________________
_______________________________________________________
_______________________________________________________
21.2.2 What quality of water is used for analyses and for the
preparation of standards ?
_______________________________________________________
_______________________________________________________
______________________________________________________
_____________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
21.2.7 Was the method used to certify the in-house standard specific ?
______________________________________________________
______________________________________________________
___________________________________________________________
____________________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
21.3.3 Examine a test where a volumetric solution was used. Was the
titre correctly recorded in the notebook ?
___________________________________________________
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 31 of 35
__________________________________________________
____________________________________________________________
___________________________________________________________
____________________________________________________________
___________________________________________________________
____________________________________________________________
___________________________________________________________
22.1.3 Does the procedure require a written explanation of the reason for
the retest ?
____________________________________________________________
___________________________________________________________
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 32 of 35
______________________________________________________________
______________________________________________________________
23.2 Are raw data reviewed prior to release from the laboratory by a person
other than the analyst who performed the test ?
______________________________________________________________
______________________________________________________________
_________________________________________________________
_________________________________________________________
23.2.2 Do reviewers sign the notebook to indicate that it has been reviewed ?
_________________________________________________________
_________________________________________________________
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 33 of 35
_________________________________________________________
_________________________________________________________
_______________________________________________________________
_______________________________________________________________
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 34 of 35
MICROBIOLOGICAL LABORATORY
25.1 Is there an SOP for the receipt and handling of ATCC cultures ?
________________________________________________________
________________________________________________________
________________________________________________________
________________________________________________________
________________________________________________________
________________________________________________________
________________________________________________________
25.3.2 Is it adhered to ?
________________________________________________________
________________________________________________________
VIVEK PHARMACHEM (INDIA) LIMITED
SELF INSPECTION AUDIT CHECKLIST
QUALITY-ASSURANCE Page 35 of 35
____________________________________________________________
____________________________________________________________
26.2 Are there written records of air pressures checked and signed ?
____________________________________________________________
____________________________________________________________
____________________________________________________
____________________________________________________
____________________________________________________
_____________________________________________________
____________________________________________________
____________________________________________________
__________________________________________________
__________________________________________________